Beloc ZOK 50 Research Overview
Beloc ZOK 50 is a selective beta-1 adrenoceptor antagonist research compound containing metoprolol succinate in an extended-release formulation. This pharmaceutical-grade material from AstraZeneca enables researchers at Stroid UK Shop to investigate beta-blocker mechanisms and cardiovascular pharmacology in controlled laboratory environments. The ZOK formulation employs controlled-release technology, allowing sustained compound availability for extended research protocols. Metoprolol succinate demonstrates selective beta-1 receptor binding affinity, making it valuable for studies examining adrenergic pathway modulation in cardiovascular tissue models.
Laboratory Research Applications
Research teams examine metoprolol succinate’s beta-adrenoceptor blocking activity across multiple experimental paradigms. Studies investigate cardiac contractility modulation, vascular smooth muscle responses, and blood pressure regulation mechanisms in laboratory models. The compound’s selectivity profile enables researchers to differentiate beta-1 versus beta-2 receptor-mediated effects in tissue preparations. Scientists studying cardiovascular pharmacology utilise this material to examine renin-angiotensin system interactions and sympathetic nervous system modulation. Extended-release formulation characteristics allow investigation of sustained pharmacokinetic profiles and dose-response relationships over prolonged experimental timeframes. Research applications encompass cardiac electrophysiology studies, examining effects on heart rate variability and conduction parameters in isolated tissue preparations.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Metoprolol Succinate |
| Strength | 50mg Extended-Release |
| Manufacturer | AstraZeneca |
| CAS Number | 98418-47-4 |
| Molecular Formula | C₁₇H₂₇NO₇ |
| Molecular Weight | 357.4 g/mol |
| Storage Requirements | Room temperature, dry conditions |
This pharmaceutical-grade material maintains consistent quality standards for research applications. Researchers also explore complementary compounds including SARMs and peptides for comprehensive cardiovascular research protocols.
Research Use Compliance
Beloc ZOK 50 is supplied exclusively for in-vitro laboratory research applications. This compound is not intended for human consumption, clinical use, or any therapeutic applications. Researchers must maintain appropriate laboratory safety protocols and comply with all applicable regulations when handling this material. Purchase and use is restricted to qualified research institutions and licensed laboratories conducting legitimate scientific investigations.
